0001104659-22-059941.txt : 20220513 0001104659-22-059941.hdr.sgml : 20220513 20220513090949 ACCESSION NUMBER: 0001104659-22-059941 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20220331 FILED AS OF DATE: 20220513 DATE AS OF CHANGE: 20220513 EFFECTIVENESS DATE: 20220513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Foresite Capital Opportunity Management V, LLC CENTRAL INDEX KEY: 0001792207 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-21821 FILM NUMBER: 22920494 BUSINESS ADDRESS: STREET 1: 900 LARKSPUR LANDING CIRCLE, SUITE 150 CITY: LARKSPUR STATE: CA ZIP: 94939 BUSINESS PHONE: 415-877-4887 MAIL ADDRESS: STREET 1: 900 LARKSPUR LANDING CIRCLE, SUITE 150 CITY: LARKSPUR STATE: CA ZIP: 94939 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001792207 XXXXXXXX 03-31-2022 03-31-2022 false Foresite Capital Opportunity Management V, LLC

900 Larkspur Landing Circle, Suite 150 Larkspur CA 94939

13F HOLDINGS REPORT 028-21821 N James B. Tananbaum 415-877-4887 /s/ James B. Tananbaum San Francisco CA 05-13-2022 0 10 71417 INFORMATION TABLE 2 infotable.xml Adicet Bio, Inc. COM 007002108 3395 170000 SH SOLE 170000 0 0 Compass Therapeutics, Inc. COM 20454B104 1507 1100000 SH SOLE 1100000 0 0 Cullinan Oncology, Inc. COM 230031106 3464 330836 SH SOLE 330836 0 0 Cue Health Inc. COM 229790100 4138 641483 SH SOLE 641483 0 0 Enanta Pharmaceuticals, Inc. COM 29251M106 1619 22750 SH SOLE 22750 0 0 Gemini Therapeutics, Inc. COM 36870G105 3385 2435125 SH SOLE 2435125 0 0 Kinnate Biopharma Inc. COM 49705R105 3284 291667 SH SOLE 291667 0 0 Pardes Biosciences Inc COM 69945Q105 37741 5227307 SH SOLE 5227307 0 0 Quantum-Si Incorporated COM CL A 74765K105 7479 1598125 SH SOLE 1598125 0 0 Theseus Pharmaceuticals, Inc. COM 88369M101 5405 468820 SH SOLE 468820 0 0